Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SANUWAVE Health (SNWV) Other financing activities (2019 - 2020)

SANUWAVE Health has reported Other financing activities over the past 2 years, most recently at $16000.0 for Q2 2020.

Quarterly Other financing activities fell 91.11% to $16000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $16000.0 through Dec 2025, down 11.59% year-over-year, with the annual reading at $371000.0 for FY2025, N/A changed from the prior year.
Other financing activities was $16000.0 for Q2 2020 at SANUWAVE Health, up from $2098.0 in the prior quarter.
Over five years, Other financing activities peaked at $180000.0 in Q2 2019 and troughed at -$180000.0 in Q3 2019.